Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice

Outcomes of the use of the glycosaminoglycan-peptide complex as monotherapy and in combination with diacerein for the treatment of knee osteoarthritis in real-world practice

Background. Slow-acting symptomatic agents (chondroprotectors) in osteoarthritis (OA) combined therapy is a promising approach. Aim. To compare the real-world results of combined therapy with glycosaminoglycan-peptide complex (GPC) and diacerein with GPC monotherapy in treating knee OA. Materi...

Full description

Bibliographic Details
Main Authors: Andrey E. Karateev, Elena Iu. Polishchuk, Alena S. Potapova, Elena V. Matyanova, Ekaterina S. Filatova, Svetlana I. Glukhova, Aleksander M. Lila
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2023-05-01
Series:Consilium Medicum
Subjects:
osteoarthritis
glycosaminoglycan-peptide complex
diacerein
combination
efficacy
safety
Online Access:https://consilium.orscience.ru/2075-1753/article/viewFile/553441/132691

Internet

https://consilium.orscience.ru/2075-1753/article/viewFile/553441/132691

Similar Items